Search research articles
Contact Us
Filters
Showing results (1-10 of 41) with videos related to
Page
of 5
Sort By:
IEEE Transactions on Neural Networks and Learning Systems
|
March 3, 2025
When Heterophily Meets Heterogeneous Graphs: Latent Graphs Guided Unsupervised Representation Learning
Zhixiang Shen, Zhao Kang
Medicine
|
November 5, 2025
Association of systemic immune-inflammatory index with all-cause and cardiovascular mortality among individuals with diabetes: Evidence from the NHANES 2001 to 2018
Mingfang Jiang, Quan Liu, Yamei Zhang, et al.
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi
|
March 18, 2015
[A multicenter clinical trial of caffeic acid tablet in treatment of 103 primary immune thrombocytopenia patients]
Ping Qin, Yu Wei, Ming Hou, et al.
Zhongguo Zhen Jiu = Chinese Acupuncture & Moxibustion
|
December 13, 2017
[Strategy programming for acupuncture development along One-Belt-One-Road countries]
Yuyang Yang, Zhixiang Shen, Zhongchao Wu, et al.
Annals of Hematology
|
September 7, 2014
Analysis of prognostic factors and comparison of prognostic scores in peripheral T cell lymphoma, not otherwise specified: a single-institution study of 105 Chinese patients
Pengpeng Xu, Dong Yu, Li Wang, et al.
Experimental and Therapeutic Medicine
|
March 27, 2014
Endostar combined with radiotherapy increases radiation sensitivity by decreasing the expression of TGF-β1, HIF-1α and bFGF
Yaogui Wu, Yongfa Zheng, Zhixiang Shen, et al.
Annals of Hematology
|
August 3, 2014
The Glasgow Prognostic Score as a significant predictor of diffuse large B cell lymphoma treated with R-CHOP in China
Xiaoyang Li, Yunxiang Zhang, Weili Zhao, et al.
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi
|
October 24, 2014
[Clinical features and prognostic analysis of 75 primary myelofibrosis patients]
Qing Yu, Lan Xu, Xiaodong Gao, et al.
Clinical Therapeutics
|
August 22, 2009
Nilotinib for imatinib-resistant or -intolerant chronic myeloid leukemia in chronic phase, accelerated phase, or blast crisis: a single- and multiple-dose, open-label pharmacokinetic study in Chinese patients
Li Zhou, Fanyi Meng, Ophelia Yin, et al.
Cancer Communications (London, England)
|
May 31, 2018
Safety and efficacy of obinutuzumab in Chinese patients with B-cell lymphomas: a secondary analysis of the GERSHWIN trial
Yan Qin, Yuqin Song, Zhixiang Shen, et al.
Page
of 5
Search research articles
Search
Showing results (1-10 of 41) with videos related to
Sort By:
Page
of 5
IEEE Transactions on Neural Networks and Learning Systems
|
March 3, 2025
When Heterophily Meets Heterogeneous Graphs: Latent Graphs Guided Unsupervised Representation Learning
Zhixiang Shen, Zhao Kang
Medicine
|
November 5, 2025
Association of systemic immune-inflammatory index with all-cause and cardiovascular mortality among individuals with diabetes: Evidence from the NHANES 2001 to 2018
Mingfang Jiang, Quan Liu, Yamei Zhang, et al.
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi
|
March 18, 2015
[A multicenter clinical trial of caffeic acid tablet in treatment of 103 primary immune thrombocytopenia patients]
Ping Qin, Yu Wei, Ming Hou, et al.
Zhongguo Zhen Jiu = Chinese Acupuncture & Moxibustion
|
December 13, 2017
[Strategy programming for acupuncture development along One-Belt-One-Road countries]
Yuyang Yang, Zhixiang Shen, Zhongchao Wu, et al.
Annals of Hematology
|
September 7, 2014
Analysis of prognostic factors and comparison of prognostic scores in peripheral T cell lymphoma, not otherwise specified: a single-institution study of 105 Chinese patients
Pengpeng Xu, Dong Yu, Li Wang, et al.
Experimental and Therapeutic Medicine
|
March 27, 2014
Endostar combined with radiotherapy increases radiation sensitivity by decreasing the expression of TGF-β1, HIF-1α and bFGF
Yaogui Wu, Yongfa Zheng, Zhixiang Shen, et al.
Annals of Hematology
|
August 3, 2014
The Glasgow Prognostic Score as a significant predictor of diffuse large B cell lymphoma treated with R-CHOP in China
Xiaoyang Li, Yunxiang Zhang, Weili Zhao, et al.
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi
|
October 24, 2014
[Clinical features and prognostic analysis of 75 primary myelofibrosis patients]
Qing Yu, Lan Xu, Xiaodong Gao, et al.
Clinical Therapeutics
|
August 22, 2009
Nilotinib for imatinib-resistant or -intolerant chronic myeloid leukemia in chronic phase, accelerated phase, or blast crisis: a single- and multiple-dose, open-label pharmacokinetic study in Chinese patients
Li Zhou, Fanyi Meng, Ophelia Yin, et al.
Cancer Communications (London, England)
|
May 31, 2018
Safety and efficacy of obinutuzumab in Chinese patients with B-cell lymphomas: a secondary analysis of the GERSHWIN trial
Yan Qin, Yuqin Song, Zhixiang Shen, et al.
Page
of 5